EQS-News: Endexx Corporation Embarks on Strategic Transformation: Leadership Evolution and Intensified Focus on HYLA's Market Dominance

CAVE CREEK, AZ -

(NewMediaWire) - March 12, 2024 -

Reflecting on the upcoming changes, Todd Davis expressed optimism remarking, "Redirecting my focus towards CBD Unlimited offers a great opportunity to foster innovation and scale, paralleling the ambitious trajectory we envision for HYLA. Under the board’s guidance, and in tandem with our distinguished management consulting firm, we are embarking on a new chapter that promises to elevate the company."

HYLA, with its revolutionary plant-based vape products made in Los Angeles, has not only captured a significant share of the market but has also established new industry benchmarks with its audacious 300% compound annual growth rate target over the next 3-5 years. This has propelled HYLA into securing expansive distribution networks across over ten countries, affirming its role as a pivotal growth engine for Endexx Corporation.

Updates on the leadership transition, strategic reorganization, and the CEO search process will be communicated as developments unfold. Endexx is dedicated to leading through innovation, excelling in execution, and sustaining its leadership in the global wellness market.

About Endexx Corporation

Endexx Corporation develops and distributes all-natural, plant-derived wellness products and topical skincare products.  Its products vary from balms, creams, lotions, butter, masks, scrubs, and oils, all with the shared purpose of healthy skin and grooming wellness.  The science behind these products involves a decade of clinical research in the field and lab work to provide a functional formulation with ingredients for optimal absorption and support of skin health. www.endexx.com

Hyla currently markets its proprietary non-nicotine, guarana and L-Dopa-based vape products in a wide variety of flavors. The Hyla device is the first non-nicotine vape product to be produced in this manner in the United States and provides an unprecedented 4,500 puffs per device. Hyla is currently being distributed in 10 countries and has signed distribution agreements with an additional nine countries. www.tryhyla.com

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995

This presentation may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief, or current expectations of the Company, its directors, or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements.  Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions, and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

No Offer or Solicitation. This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.  No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and, where applicable, the requirements under the securities laws of any other applicable jurisdiction.

For further details, please contact:

Endexx Corporation

IR@Endexx.com